Governance

Our Board of Directors comprises key industry players who are recognized for their expertise and come from biotech, big pharma, universities and the agri-tech sector, as well as representatives from Luxembourg Province and the Walloon Region!

Administrators on the Board of Directors of the CER Groupe

• BONTEMPS Philippe, Province du Luxembourg - Vice-President
• VANLOOCKE Olivier, CER Groupe - Administrator-Director
• BARET Philippe, UCL - Administrator
• BOUREZ Sophie, Wagralim - Administrator
• CASTILLO José, Univercells - Administrator
• DE BORMAN Béatrice, DIAsource ImmunoAssays - Administrator
• DENOEL Philippe, GSK Vaccines - Administrator
• DIVOY Christian, Agriculteur - Administrator
• GILLARD Dominique, Province du Luxembourg - Administrator
• GLATT Sophie, UCB - Administrator
• GRAVY Sophie, plusOne - Administrator
• MASSARD Christian, Province du Luxembourg - Administrator
• MOREAUX Benoit, QbD - Administrator
• SMETS Katelijne, ARSIA - Administrator
• VINCENT Stéphane, UNamur - Administrator

Observers on the Board of Directors of the CER Groupe

• BASTIAENS Annette, Walloon Region - Observer
• LEONARD Sophie, Walloon Region - Observer
• GORIELY Stanislas, ULB - Observer

Strategic Committee

The roles of the Strategic Committee are :

• define a strategy and propose an implementation plan to the Board of Directors
• monitor the execution of the strategic plan by the Management Committee
• monitor the development of the environment and correct the strategic plan if necessary

Members of the Strategic Committee :

• DENOËL Philippe - President Biowin & GSK
• BOUCHAT Jean-Claude - CEO ECI
• WALLEMACK Hugues - Exo Biologics
• DEMONTÉ Dominique - Brussels South Charleroi Biopark (BSCB)
• DECHAMPS Marc - Biowin, CEBR
• DESMECHT Daniel - ULg
• LIZIN Pascal - Board member in several companies
• VAN PUTTE Anthony - Pôle Mecatech
• VANLOOCKE Olivier - CEO of the CER Groupe

Audit Committee

The Audit Committee assists the Board of Directors in its oversight and monitoring duties in the following areas:

• the correct application of accounting principles, as well as any changes that may be made to them in the light of changes in legislation;
• the quality and efficiency of the financial reporting process ;
• the analysis of the Foundation's budget, annual accounts and consolidated accounts, including inter-subsidiary transfers, as well as the annual management reports and the auditor's reports on this subject Analysis and follow-up of any significant adjustments to be made on the recommendation of the auditor in the context of the statutory audit;
• the analysis of any interim financial statements and any other financial communications to third parties;
• the analysis of all other important accounting, tax and financial reporting issues, including the reporting of complex and/or non-routine transactions.

Members of the Audit Committee:

• GÉNARD Brigitte - Administrator
• MORRO Terry - CFO West Europe Omaya
• VANDEBROEK Jean-Luc - CFO Hyloris